🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Allogeneic (Allo) hematopoietic stem cell transplantation (HSCT) is a recog...
Status
Completed
Location
CHU Amiens
Start Date
2016-02-23
Trial ID
NCT02623309
Treatments Being Tested
T-cell acute lymphoblastic leukemia (T-ALL), a hematological malignant neop...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2024-12-01
Trial ID
NCT06673459
This study is a multicenter, single-arm, prospective phase II clinical tria...
Status
Recruiting
Location
Shanghai General Hospital
Start Date
2024-01-20
Trial ID
NCT06111612
T cell acute lymphoblastic leukemia (T-ALL)/Lymphoblastic lymphoma (LBL) is...
Status
Unknown
Location
The First Affiliated Hospital, College of Medicine, Zhejiang University
Start Date
2022-10-23
Trial ID
NCT05598593
Treatments Being Tested
Background: Allogeneic blood or marrow transplant is when stem cells are t...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2015-11-19
Trial ID
NCT02579967
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) appears to b...
Status
Completed
Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Start Date
2016-04-18
Trial ID
NCT02744742
Treatments Being Tested
This is a single-institution, phase II study to determine the event-free su...
Status
Completed
Location
University of Minnesota Masonic Cancer Center and Medical Center
Start Date
2016-03
Trial ID
NCT02582775
The main purpose of the project is to evaluate the disease free survival an...
Status
Unknown
Location
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Start Date
2018-09-15
Trial ID
NCT03339700
Treatments Being Tested
Allo-HSCT is the most effective way to cure sAML patients. At present, the ...
Status
Unknown
Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Start Date
2022-07
Trial ID
NCT05449899
Relapse remains a principle cause of treatment failure for patients with ag...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2010-08
Trial ID
NCT01181271
Treatments Being Tested